Annual Current Assets
$11.83 B
-$295.84 M-2.44%
01 December 2023
Summary:
Sinovac Biotech annual total current assets is currently $11.83 billion, with the most recent change of -$295.84 million (-2.44%) on 01 December 2023. During the last 3 years, it has risen by +$10.27 billion (+658.23%). SVA annual current assets is now -20.68% below its all-time high of $14.92 billion, reached on 31 December 2021.SVA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$11.15 B
-$682.28 M-5.77%
01 June 2024
Summary:
Sinovac Biotech quarterly total current assets is currently $11.15 billion, with the most recent change of -$682.28 million (-5.77%) on 01 June 2024. Over the past year, it has dropped by -$682.28 million (-5.77%). SVA quarterly current assets is now -25.26% below its all-time high of $14.92 billion, reached on 31 December 2021.SVA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -5.8% |
| 3 y3 years | +658.2% | -4.6% |
| 5 y5 years | +4063.1% | +3457.7% |
SVA Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.7% | +658.2% | -25.3% | at low |
| 5 y | 5 years | -20.7% | +4063.1% | -25.3% | +3457.7% |
| alltime | all time | -20.7% | >+9999.0% | -25.3% | >+9999.0% |
Sinovac Biotech Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $11.15 B(-5.8%) |
| Dec 2023 | $1.83 B(-8.1%) | $11.83 B(+0.5%) |
| June 2023 | - | $11.77 B(-2.9%) |
| Dec 2022 | $1.99 B(+8.5%) | $12.13 B(-7.5%) |
| June 2022 | - | $13.12 B(-12.1%) |
| Dec 2021 | $1.83 B(+437.5%) | $14.92 B(+27.6%) |
| June 2021 | - | $11.69 B(+649.2%) |
| Dec 2020 | $341.03 M(+232.1%) | $1.56 B(+267.3%) |
| Sept 2020 | - | $424.77 M(+25.7%) |
| June 2020 | - | $338.00 M(+2.6%) |
| Mar 2020 | - | $329.35 M(-5.8%) |
| Dec 2019 | $102.69 M(+20.0%) | $349.61 M(+11.6%) |
| Sept 2019 | - | $313.36 M(+3.2%) |
| June 2019 | - | $303.79 M(+7.3%) |
| Mar 2019 | - | $283.22 M(-0.3%) |
| Dec 2018 | $85.61 M(-10.2%) | $284.18 M(+33.4%) |
| June 2018 | - | $213.06 M(+4.5%) |
| Dec 2017 | $95.33 M(+18.3%) | $203.89 M(+25.5%) |
| June 2017 | - | $162.41 M(+24.2%) |
| Dec 2016 | $80.61 M(+8.3%) | $130.75 M(+3.8%) |
| Sept 2016 | - | $125.94 M(+17.9%) |
| June 2016 | - | $106.82 M(-16.7%) |
| Mar 2016 | - | $128.17 M(-0.2%) |
| Dec 2015 | $74.43 M(-11.1%) | $128.49 M(+3.3%) |
| Sept 2015 | - | $124.38 M(-7.8%) |
| June 2015 | - | $134.95 M(+4.8%) |
| Mar 2015 | - | $128.78 M(-16.8%) |
| Dec 2014 | $83.73 M(+0.3%) | $154.80 M(-1.6%) |
| Sept 2014 | - | $157.34 M(+6.7%) |
| June 2014 | - | $147.42 M(-6.0%) |
| Mar 2014 | - | $156.90 M(-0.2%) |
| Dec 2013 | $83.44 M(+1.2%) | $157.25 M(+8.7%) |
| Sept 2013 | - | $144.69 M(+2.7%) |
| June 2013 | - | $140.87 M(+5.5%) |
| Mar 2013 | - | $133.51 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $82.48 M(-1.7%) | $126.28 M(+3.3%) |
| Sept 2012 | - | $122.28 M(-1.1%) |
| June 2012 | - | $123.61 M(-0.4%) |
| Mar 2012 | - | $124.08 M(-6.0%) |
| Dec 2011 | $83.87 M(+25.1%) | $132.04 M(+1.1%) |
| Sept 2011 | - | $130.63 M(+0.8%) |
| June 2011 | - | $129.62 M(-3.6%) |
| Mar 2011 | - | $134.52 M(-8.7%) |
| Dec 2010 | $67.06 M(+156.3%) | $147.29 M(-4.6%) |
| Sept 2010 | - | $154.41 M(-0.0%) |
| June 2010 | - | $154.43 M(-8.6%) |
| Mar 2010 | - | $168.99 M(+41.6%) |
| Dec 2009 | $26.16 M(+25.1%) | $119.31 M(+21.0%) |
| Sept 2009 | - | $98.59 M(+8.1%) |
| June 2009 | - | $91.21 M(+59.1%) |
| Mar 2009 | - | $57.34 M(-7.9%) |
| Dec 2008 | $20.92 M(+14.5%) | $62.28 M(+12.1%) |
| Sept 2008 | - | $55.57 M(-3.0%) |
| June 2008 | - | $57.27 M(+18.3%) |
| Mar 2008 | - | $48.42 M(+23.6%) |
| Dec 2007 | $18.27 M(+19.6%) | $39.18 M(+11.3%) |
| Sept 2007 | - | $35.20 M(+18.6%) |
| June 2007 | - | $29.69 M(+36.6%) |
| Dec 2006 | $15.27 M(+1.6%) | $21.74 M(+29.2%) |
| June 2006 | - | $16.83 M(+3.4%) |
| Dec 2005 | $15.03 M(+7.7%) | $16.27 M(+109.7%) |
| June 2005 | - | $7.76 M(-8.4%) |
| Dec 2004 | $13.95 M(+27.4%) | $8.47 M(+2.4%) |
| Sept 2004 | - | $8.27 M(-8.6%) |
| June 2004 | - | $9.05 M(+129.0%) |
| Dec 2003 | $10.95 M(>+9900.0%) | $3.95 M |
| Apr 2002 | $69.90 K(-32.5%) | - |
| Apr 2001 | $103.60 K(+95.5%) | - |
| Apr 2000 | $53.00 K(>+9900.0%) | - |
| Apr 1999 | $0.00 | - |
FAQ
- What is Sinovac Biotech annual total current assets?
- What is the all time high annual current assets for Sinovac Biotech?
- What is Sinovac Biotech quarterly total current assets?
- What is the all time high quarterly current assets for Sinovac Biotech?
- What is Sinovac Biotech quarterly current assets year-on-year change?
What is Sinovac Biotech annual total current assets?
The current annual current assets of SVA is $11.83 B
What is the all time high annual current assets for Sinovac Biotech?
Sinovac Biotech all-time high annual total current assets is $14.92 B
What is Sinovac Biotech quarterly total current assets?
The current quarterly current assets of SVA is $11.15 B
What is the all time high quarterly current assets for Sinovac Biotech?
Sinovac Biotech all-time high quarterly total current assets is $14.92 B
What is Sinovac Biotech quarterly current assets year-on-year change?
Over the past year, SVA quarterly total current assets has changed by -$682.28 M (-5.77%)